HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation

Molecular Biology of the Cell

Volumn 14, Issue 3, 2003, Pages 926-938

  Markosyan, Ruben M ^a   Cohen, Fredric S ^a   Melikyan, Grigory B ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; HYBRID PROTEIN; PEPTIDE DERIVATIVE; VIRUS ENVELOPE PROTEIN;

ARTICLE; CHANNEL GATING; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LOW TEMPERATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE; TARGET CELL; TECHNIQUE;

ANIMALS; ANTIGENS, CD4; CELL LINE; FLUORESCENT DYES; GENE PRODUCTS, ENV; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MEMBRANE FUSION; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CXCR4; TEMPERATURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037340005     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-09-0573     Document Type: Article

References (39)

1. Cao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H., and Sodroski, J. (1993). Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67, 2747-2755.
2. Chan, D.C., Chutkowski, C.T., and Kim, P.S. (1998). Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl. Acad. Sci. USA 95, 15613-15617.
3. Chan, D.C., and Kim, P.S. (1998). HIV entry and its inhibition. Cell 93, 681-684.
4. Chen, C.H., Matthews, T.J., McDanal, C.B., Bolognesi, D.P., and Greenberg, M.L. (1995). A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol. 69, 3771-3777.
5. Chernomordik, L., Kozlov, M.M., and Zimmerberg, J. (1995). Lipids in biological membrane fusion. J. Membr. Biol. 146, 1-14.
6. Coorssen, J.R., Blank, P.S., Tahara, M., and Zimmerberg, J. (1998). Biochemical and functional studies of cortical vesicle fusion: the SNARE complex and Ca2+ sensitivity. J. Cell Biol. 143, 1845-1857.
7. de Rosny, E., Vassell, R., Wingfield, P.T., Wild, C.T., and Weiss, C.D. (2001). Peptides corresponding to the heptad repeat motifs in the transmembrane protein (gp41) of human immunodeficiency virus type 1 elicit antibodies to receptor-activated conformations of the envelope glycoprotein. J. Virol. 75, 8859-8863.
8. Deng, H.K., Unutmaz, D., KewalRamani, V.N., and Littman, D.R. (1997). Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300.
9. Dubay, J.W., Roberts, S.J., Brody, B., and Hunter, E. (1992). Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66, 4748-4756.
10. Durrer, P., Galli, C., Hoenke, S., Corti, C., Gluck, R., Vorherr, T., and Brunner, J. (1996). H+-induced membrane insertion of infiuenza influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem. 271, 13417-13421.
11. Eckert, D.M., and Kim, P.S. (2001). Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70, 777-810.
12. Endres, M.J. et al. (1996). CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756.
13. Gallo, S.A., Puri, A., and Blumenthal, R. (2001). HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry 40, 12231-12236.
14. Golding, H. et al. (2002). Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J. Virol. 76, 6780-6790.
15. Hernandez, L.D., Hoffman, L.R., Wolfsberg, T.G., and White, J.M. (1996). Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12, 627-661.
16. Jahn, R., and Sudhof, T.C. (1999). Membrane fusion and exocytosis. Annu. Rev. Biochem. 68, 863-911.
17. Ji, H., Shu, W., Burling, F.T., Jiang, S., and Lu, M. (1999). Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusion. J. Virol. 73, 8578-8586.
18. Jiang, S., Lin, K., Strick, N., and Neurath, A.R. (1993). HIV-1 inhibition by a peptide. Nature 365, 113.
19. Kilby, J.M. et al. (1998). Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4, 1302-1307.
20. Kliger, Y., and Shai, Y. (2000). Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. J. Mol. Biol. 295, 163-168.
21. Lee, B., Sharron, M., Montaner, L.J., Weissman, D., and Doms, R.W. (1999). Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 96, 5215-5220.
22. Lu, M., Blacklow, S.C., and Kim, P.S. (1995). A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2, 1075-1082.
23. Lu, M., Stoller, M.O., Wang, S., Liu, J., Fagan, M.B., and Nunberg, J.H. (2001). Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis. J. Virol. 75, 11146-11156.
24. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A., and Axel, R. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
25. Markosyan, R.M., Cohen, F.S., and Melikyan, G.B. (2000). The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol. Biol. Cell 11, 1143-1152.
26. Markosyan, R.M., Ma, X., Lu, M., Cohen, F.S., and Melikyan, G.B. (2002). The mechanism of inhibition of HIV-1 Env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain. Virology 302, 174-184.
27. Mayer, A. (2001). What drives membrane fusion in eukaryotes? Trends Biochem. Sci. 26, 717-723.
28. Melikyan, G.B., Lin, S., Roth, M.G., and Cohen, F.S. (1999). Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol. Biol. Cell 10, 1821-1836.
29. Melikyan, G.B., Markosyan, R.M., Brener, S.A., Rozenberg, Y., and Cohen, F.S. (2000a). Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation. J. Virol. 74, 447-455.
30. Melikyan, G.B., Markosyan, R.M., Hemmati, H., Delmedico, M.K., Lambert, D.M., and Cohen, F.S. (2000b). Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol. 151, 413-424.
31. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., and Blumenthal, R. (1998). Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140, 315-323.
32. Poirier, M.A., Xiao, W., Macosko, J.C., Chan, C., Shin, Y.K., and Bennett, M.K. (1998). The synaptic SNARE complex is a parallel four-stranded helical bundle. Nat. Struct. Biol. 5, 765-769.
33. Russell, C.J., Jardetzky, T.S., and Lamb, R.A. (2001). Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J. 20, 4024-4034.
34. Skehel, J.J., and Wiley, D.C. (2000). Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569.
35. Sutton, R.B., Fasshauer, D., Jahn, R., and Brunger, A.T. (1998). Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395, 347-353.
36. Tokunaga, K., Greenberg, M.L., Morse, M.A., Cumming, R.I., Lyerly, H.K., and Cullen, B.R. (2001). Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J. Virol. 75, 6776-6785.
37. Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J., and Wiley, D.C. (1997). Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430.
38. Weng, Y., Yang, Z., and Weiss, C.D. (2000). Structure-function studies of the self-assembly domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 74, 5368-5372.
39. Wild, C.T., Shugars, D.C., Greenwell, T.K., McDanal, C.B., and Matthews, T.J. (1994). Peptides corresponding to a predictive alphahelical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.